Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes

IN BRIEF This article describes a single-center, retrospective chart review to determine the glycemic effect of converting from U-100 to U-500 regular insulin in veterans with type 2 diabetes and the effect of this change, if any, on the frequency of provider contacts. Results showed that U-500 insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Joseph A., Nawarskas, Ann D., Resch, Nina D., Vigil, Justina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299745/
https://www.ncbi.nlm.nih.gov/pubmed/25653468
http://dx.doi.org/10.2337/diaclin.33.1.14
_version_ 1782353434333151232
author Granata, Joseph A.
Nawarskas, Ann D.
Resch, Nina D.
Vigil, Justina M.
author_facet Granata, Joseph A.
Nawarskas, Ann D.
Resch, Nina D.
Vigil, Justina M.
author_sort Granata, Joseph A.
collection PubMed
description IN BRIEF This article describes a single-center, retrospective chart review to determine the glycemic effect of converting from U-100 to U-500 regular insulin in veterans with type 2 diabetes and the effect of this change, if any, on the frequency of provider contacts. Results showed that U-500 insulin improved glycemic control without significantly increasing the risk of hypoglycemia or total daily insulin dose, even when follow-up contacts with providers were not structured or frequent.
format Online
Article
Text
id pubmed-4299745
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-42997452016-01-01 Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes Granata, Joseph A. Nawarskas, Ann D. Resch, Nina D. Vigil, Justina M. Clin Diabetes Feature Articles IN BRIEF This article describes a single-center, retrospective chart review to determine the glycemic effect of converting from U-100 to U-500 regular insulin in veterans with type 2 diabetes and the effect of this change, if any, on the frequency of provider contacts. Results showed that U-500 insulin improved glycemic control without significantly increasing the risk of hypoglycemia or total daily insulin dose, even when follow-up contacts with providers were not structured or frequent. American Diabetes Association 2015-01 /pmc/articles/PMC4299745/ /pubmed/25653468 http://dx.doi.org/10.2337/diaclin.33.1.14 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
spellingShingle Feature Articles
Granata, Joseph A.
Nawarskas, Ann D.
Resch, Nina D.
Vigil, Justina M.
Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title_full Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title_fullStr Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title_full_unstemmed Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title_short Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
title_sort evaluating the effect of u-500 insulin therapy on glycemic control in veterans with type 2 diabetes
topic Feature Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299745/
https://www.ncbi.nlm.nih.gov/pubmed/25653468
http://dx.doi.org/10.2337/diaclin.33.1.14
work_keys_str_mv AT granatajosepha evaluatingtheeffectofu500insulintherapyonglycemiccontrolinveteranswithtype2diabetes
AT nawarskasannd evaluatingtheeffectofu500insulintherapyonglycemiccontrolinveteranswithtype2diabetes
AT reschninad evaluatingtheeffectofu500insulintherapyonglycemiccontrolinveteranswithtype2diabetes
AT vigiljustinam evaluatingtheeffectofu500insulintherapyonglycemiccontrolinveteranswithtype2diabetes

Ejemplares similares